Results 91 to 100 of about 197,499 (175)

Exposure to polybrominated diphenyl ethers (PBDEs) suppresses the release of pro-inflammatory products by alveolar macrophages in vitro [PDF]

, 2010
Endocrine disrupting chemicals have adverse effects on immune function that may result in respiratory conditions. Inhalation of dust is a major route of exposure to PBDEs; however, the impact of PBDEs on the immune response is unclear.
Hennigar, Stephen R
core   +1 more source

Relations of environmental contaminants, algal toxins, and diet with the reproductive success of American alligators on Florida Lakes [PDF]

, 2001
(113 page ...
Arnold, Beverly S., Gross, Timothy S., McDonald, Kelly, Spulveda, Maria S.   +3 more
core  

Long-Acting Growth Hormone in Idiopathic Short Stature [PDF]

Hormone Research in Paediatrics, 2018
Paul, Saenger, Luis, Zamora-Siliezar
openaire   +2 more sources

First experience with long-acting growth hormone

Česko-slovenská pediatrie, 2022
Jan Lebl, Ledjona Toni, Adriana Dankovčíková, Ľudmila Košťálová, Olga Magnová, Stanislava Koloušková   +5 more
openaire   +1 more source

Editorial: History of Growth Hormone: Animal to Human

Frontiers in Endocrinology, 2021
Edward O. Reiter, Laurie E. Cohen, Alan D. Rogol   +2 more
doaj   +1 more source

Usability and Preference Evaluation of the Somapacitan Pen-Injector and Lonapegsomatropin Autoinjector: Results of a US-Based Simulated-Use Study with Adolescent Patients and Caregivers

Patient Preference and Adherence
Johan Medina,1 Gitte Ter-Borch,2 Nicky Kelepouris,3 Sophie Hamilton,3 Maya Gonczi,4 Jørgen Vinsløv Hansen,5 Shahid Akhtar1 1Medical & Science, Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark; 2Usability Engineering, Devices and Delivery ...
Medina J, Ter-Borch G, Kelepouris N, Hamilton S, Gonczi M, Hansen JV, Akhtar S   +6 more
doaj  

Weekly Growth Hormone Somatrogon and Clinical Use Principles

Güncel Pediatri
The recombinant human growth hormone has been used for about 40 years and is administered as a single daily dose. Long-acting growth hormones are developed to enhance therapy adherence and reduce therapy load.
Erdal Eren, Furkan Erdoğan
doaj   +1 more source

Long-term effectiveness and safety of long-acting growth hormone preparation in children with growth hormone deficiency

Journal of Pediatric Endocrinology and Metabolism
Abstract Objectives To evaluate the long-term effectiveness of weekly vs. daily growth hormone (GH) administration in children with GH deficiency. Methods This study, part of the “LG Growth Study”, included a total of 996 children ...
Eungu Kang, Lindsey Yoojin Chung, Young-Jun Rhie, Kee-Hyoung Lee, Hyo-Kyoung Nam   +4 more
openaire   +2 more sources

Study of long-acting vs daily growth hormone: peak levels, AUC, action duration, and IGF-1

Academia Biology
Introduction: Long-acting growth hormone (LAGH) therapy was developed to improve adherence by reducing injection frequency compared to daily growth hormone (GH) therapy.
Ashraf Soliman, Fawzia Alyafei, Nada Alaaraj, Noor Hamed, Shayma Mohamed, Ahmed Elawwa, Vincenzo De Sanctis   +6 more
doaj   +1 more source

Correction: First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome. [PDF]

Horm Metab Res, 2022
Gao X, Chen J, Cao B, Dou X, Peng Y, Su C, Qin M, Wei L, Fan L, Zhang B, Gong C.   +10 more
europepmc   +1 more source